PAST EVENTS

Recent past events by AAPS-BADG  

September 27th, 2018 

WorkshopSmall Molecule Formulation Development — Strategies for challenging APIs (jointly with PBSS)

June 7th, 2018

Particle Engineering and Characterization of Pharmaceutical Solids for Small and Large Molecules
Speaker: Qi (Tony) Zhou, PhD – Purdue University

Cyclodextrins as Solubilization Tools for BCS Class II/IV Drugs & Biomolecules Stabilizers
Speaker: Carmen Popescu, PhD – Roquette America Inc.

March 8th, 2018 

Pharmaceutical Innovation in Academia
Speaker: Howard Maibach, MD, UCSF

Real-time GMP Manufacture of Injectable Formulations for Clinical Development: Where the Requirements of Science and Quality Meet
Speaker: Kevin M Kane, PhD, Quotient Sciences

October, 25th 2017 

Systemic Concentrations Can Limit the Oral Absorption of Poorly Soluble Drugs: An Investigation of Non-Sink Permeation Using Physiologically Based Pharmacokinetic Modeling
Speaker: Tom Chiang, Ph.D.,  Genentech, Inc   Bio and Abstract

Defining in-vitro-in-vivo Relationships for Orally Inhaled and Nasal Drug Products
Speaker: Jag Shur, Ph.D., Nanopharm Ltd. UK Bio and Abstract 

June 8, 2017

Back to the Future: Aerosol Treatment and Prevention of Tuberculosis 
Speaker: Anthony J Hickey, Ph.D.,RTI International, RTP, NC                   
Bio and Abstract

3-D Printed Pharmaceutical Dosage
Speaker: Xiaoling Li, Ph.D., University of the Pacific, Stockton, CA  
Bio and Abstract

March 30, 2017

Characterization of Polymorphs, Amorphous Solid Dispersions, and Proteins in Lyophilized Formulations Using Solid-State NMR Spectroscopy
Speaker: Dr. Eric Munson, Professor in Pharmaceutical Sciences,
Univ. of Kentucky.
Bio and Abstract

March 9, 2017

Systems based Pharmaceutics: Leveraging Mechanistic Process Modeling Tools to Meet Regulatory Requirements
Speaker: Dan Briado Senior Technical Consultant, Process Systems Enterprise Ltd. 

Developing Palatable Drug Products: It’s More than Yuck and Yum
Speaker: David A. Tisi, Technical Director, Senopsys LLC

June 19, 2014
Understanding Complex Systems: The Map is Not the Territory
Speaker: Dr. Rasmus Gronfeldt Winther, Associate Professor of Philosophy, UC Santa Cruz.

PKPD Considerations for the Preclinical Development of Antibody-Drug Conjugates
Speaker: Dr. Shraddha Sadekar, Senior Scientist, DMPK and Disposition, Merck Research Laboratories, Palo Alto.

3/27/2014
Pediatric Drugs – A Review of Commercially Available Oral Drug Products
Speaker: Dr. Robert Strickley, Principal Scientist, Gilead Sciences Inc.

Strengthening Weaker Joints: Discovery of a New Drug Candidate for Trasnthyrethin-Folding Diseases
Speaker: Dr. Mamoun Alhamadsheh, Dept. of Pharmaceutics & Medicinal Chemistry, University of the Pacific.

9/12/2013

Overcoming the Cold-Chain: Designing a Novel Freeze-Stable Vaccine
Speaker: Aryo Sorayya, President, Engimata Inc.

Models and Their Utility in the Drug Development Process
Speaker: Dr.  Toufigh Gordi, President of PK/PD and Clinical Pharmacology Services, Rose & Co LLC.

5/09/2013

Protein Particulates and Immunogenicity
Speaker: Dr. Valerie Quarmby,  Principal Scientist and Director, Genentech:

Immunogenicity in Biotherapeutic Development
Speaker: Dr. Hanns-Christian Mahler, Head Pharmaceutical Development & Supplies, F. Hoffmann-LaRoche Ltd., Pharmaceutical Division, Pharma Technical Development Biologics Europe: “To See or Not to See? – Particulates in Protein Pharmaceuticals”

3/07/2013
Formulation Development of  Monoclonal Antibodies
Speaker: Dr. Steve Shire,  Staff Scientist, Late Stage Pharmaceutical Development, Genentech: “Challenges in the Development of Formulations for the Delivery of Monoclonal Antibody Therapeutics.”
Speaker: Dr. Mitra Mosharraf, Chief Scientific Officer, HTD Biosystems: “Strategies to Improve Dissolution Rate of Lyophilized High Dose Protein Formulations in Dual Chamber Syringes.”

11/13/2012
“Oxidative Degradation of Pharmaceuticals”
Speaker: Dr. Christian Schoneich,  Takeru Higuchi Distinguished Professor and Chair, Dept. Pharmaceutical Chemistry, Univ. of Kansas: “Oxidative degradation of pharmaceuticals: mechanisms and commonalities between small molecules, peptides, and proteins.”
Speaker: Dr. Andrea Ji, Senior Scientist, Late Stage Pharmaceutical Development, Genentech: “Oxidative degradation of pharmaceutical excipients.”

07/19/2012
“Solving Drug Metabolism Challenges”
Speaker: Cyrus Khojasteh, PhD, Group Leader, DMPK Genentech
Speaker: Jason Halladay, PhD, Scientist, DMPK Genentech

04/12/2012
“New Approaches of Drug Delivery: from Particulates to Cells
Speaker: Xin Guo, PhD: “Design of biocompatible pH-sensitive liposomes for drug and gene delivery”
Speaker: Kevin Healy, PhD: “Bioinspired Approaches for Drug Delivery and Tissue Engineering”

12/01/2011
“Excipients and Drug Delivery”
Speaker: Narsi Rangachari, Ph.D. “Drug Delivery – A Prespective”
Speaker: Robert Strickley, Ph.D.  “Formulations in Drug Discovery…”

10/28/2011
“The Development of Biosimilar Drugs, Opportunities and Challenges”
SPEAKER:  YING-FEI WEI, PH.D.

06/29/2011
Why aren’t there more parenterally administered nanocarrier drug products?  Speaker:    Francis C. Szoka, PhD
Recent Innovations of liposomal products in drug development                                      Speaker:     Rajiv Nayar, PhD

 02/25/2011
Pharmaceutical Excipients – Adding Functionality to Product Development
(joint event with CACO)

 09/09/2010
Antibody Drug Conjugate/The Prospect of Therapeutic Antibodies
Speakers:      Shrikant Deshpande, PhD/Xiaodong Yang, MD PhD

 05/06/2010
Risk Management and Protein Formulation in Drug Development
Speakers:       Vijay Chiruvolu, PhD, Tim Kamerzell, PhD

 1/20/2010
Poorly Soluble Drugs-Pharmaceutical Development Strategies and
Approaches for Pre Clinical Applications (joint event with CACO)
Speakers:     Ram Nyshadham, Karthik Nagapudi, Sreekanth Nadkarni, Sesha Neravennan